Carlos Jiménez to Antineoplastic Agents
This is a "connection" page, showing publications Carlos Jiménez has written about Antineoplastic Agents.
Connection Strength
0.360
-
Jim?nez C, Ellahioui Y, ?lvarez R, Aramburu L, Riesco A, Gonz?lez M, Vicente A, Dahdouh A, Ibn Mansour A, Jim?nez C, Mart?n D, Sarmiento RG, Medarde M, Caballero E, Pel?ez R. Exploring the size adaptability of the B ring binding zone of the?colchicine site of tubulin with para-nitrogen substituted isocombretastatins. Eur J Med Chem. 2015 Jul 15; 100:210-22.
Score: 0.260
-
Masanas M, Masi? N, Su?rez-Cabrera L, Olivan M, Soriano A, Majem B, Devis-Jauregui L, Burgos-Panadero R, Jim?nez C, Rodriguez-Sodupe P, Boloix A, Toledano I, Guill?n G, Navarro A, Llobet-Navas D, Villanueva A, S?nchez de Toledo J, Roma J, Noguera R, Moreno L, Krauss R, Gallego S, Santamaria A, Segura MF. The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models. Clin Transl Med. 2021 10; 11(10):e533.
Score: 0.101